Upfront Radiotherapy with Concurrent and Adjuvant Vismodegib Is Effective and Well-Tolerated in a Patient with Advanced, Multifocal Basal Cell Carcinoma
We present a case report of a male with multifocal and extensive basal cell carcinoma. Due to extremely large size and deep tumor infiltration, he was not a surgical candidate. Combined modality treatment of fractionated radiation with concurrent vismodegib was chosen. Concurrent treatment was previ...
Saved in:
Main Authors: | Abigail I. Franco, Gary Eastwick, Ramsay Farah, Marvin Heyboer, Mijung Lee, Paul Aridgides |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Dermatological Medicine |
Online Access: | http://dx.doi.org/10.1155/2018/2354146 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face
by: Alec M. Block, et al.
Published: (2015-01-01) -
A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma
by: Dawn Odom, et al.
Published: (2017-01-01) -
Case report: Complete response of recurrent locally advanced basal cell carcinoma following addition of vismodegib to neoadjuvant cemiplimab therapy
by: Chalette Lambert-Swainston, et al.
Published: (2025-01-01) -
Nomograms Predicting Survival, Recurrence and Beneficiary Identification of Adjuvant Chemotherapy in Treatment-naïve Patients with Rectal Cancer who Underwent Upfront Curative Resection: A multi-institutional study
by: Yukihide Kanemitsu, MD, et al.
Published: (2024-12-01) -
Extensive Morphea Following Adjuvant Radiotherapy for Breast Carcinoma—Case Report
by: Alexandru Panaitescu, et al.
Published: (2025-01-01)